However, as a precautionary measure, the FDA has issued a black box warningits highest level of warningadvising against the use of these drugs in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Coverage depends on your insurance plan and medical eligibility requirements
You should not try to access retatrutide from unregulated sellers while waiting for approval
Brand names are referenced for educational comparison only
Cost, availability, insurance coverage, prior authorization and, side effects all make semaglutide unattractive to me
Novo Nordisk's semaglutide beats its counterpart liraglutide to become the next generation of weight loss innovation, and then Eli Lilly's GLP-1R/GIPR dual-target agonist tirzepatide achieves a 22.5% weight loss, surpassing semaglutide's weight loss history